UCB stock rises 1.92 percent near its yearly high

Published on 09/22/2026 at 18:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UCB stock closed at EUR 212.10 on September 21, 2026, with a EUR 41.25 billion market capitalization. Volume reached 213,832 shares.

Moderner Biopharma-Forschungscampus mit Glasgebäuden und Laborpersonal in Brüssel bei Tageslicht — UCB S.A. mit ISIN BE0003739530 zeigt modernen Forschungscampus in Brüssel mit Laborpersonal in Glasgebäuden, Illustration mit AI erstellt.

UCB stock closed at EUR 212.10 on Euronext Brussels on September 21, 2026, up 1.92 percent from the prior close. The pharmaceutical company was valued at EUR 41.25 billion, putting the market figure at the center of the latest trading picture.

Trading strength near the yearly range

The same September 21, 2026 snapshot recorded a session high of EUR 213.00 and a low of EUR 207.60, while volume reached 213,832 shares. The EUR 4.00 increase and the position close to the session high indicate that buyers controlled the quoted range during the completed trading session.

Market value leads the current signal

For investors, the comparison is clear: UCB gained 1.92 percent in one session while its market capitalization stood at EUR 41.25 billion on September 21, 2026. That combination provides a dated market benchmark without mixing the primary Brussels quotation with another venue.

UCB stock closes at EUR 212.10

UCB stock closed at EUR 212.10 on Euronext Brussels on September 21, 2026, after reaching EUR 213.00 during the session. The quoted market capitalization was EUR 41.25 billion and trading volume was 213,832 shares.